Not specified muscular elasticity, Ultrasound, Continuous Shear Wave Elastography
Conditions
Interventions
Sponsors
Shitara Hitoshi
Chikuda Hirotaka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) 18 years of age or older 2) Patients scheduled to undergo orthopedic surgery under general anesthesia 3) Patients in good general condition with a PS (Performance Status) of 2 or less 4) Patients scheduled to undergo neuromuscular monitoring and receive a muscle relaxant (rocuronium bromide) 5) Patients who do not have a disease that causes muscle atrophy or degeneration at the site of measurement 6) Patients who have no history of neuropsychiatric disorders and are not currently receiving any medical treatment. 7) Patients who have given written consent to participate in this study
Exclusion criteria
Exclusion criteria: 1) Pregnant patients 2) Patients with a history of hypersensitivity to any history of Rocuronium Bromide 3) Patients with myasthenia gravis or myasthenic syndrome who have a history of hypersensitivity to sugammadex sodium 4) Patients with a pacemaker 5) Other patients who are judged by the physician to be unsuitable for the treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of muscle elasticity (shear wave velocity) by continuous shear wave elastography before and after administration of muscle relaxants | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison between depth of muscle relaxation obtained by neuromuscular monitoring and muscle elasticity (shear wave velocity) by continuous shear wave elastography | — |
Contacts
Public ContactRyosuke Miyamoto
Gunma University Hospital
Outcome results
None listed